Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
107771173	10777117	3	F	20140620	20160915	20150209	20160921	EXP		PHHY2015DE015108	NOVARTIS		74.00	YR		F	Y	49.30000	KG	20160921		MD	DE	DE

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	CUM DOSE CHR	CUM DOSE UNIT	DECHAL	RECHAL	LOT NUM	EXP DT	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
107771173	10777117	1	PS	AFINITOR	EVEROLIMUS	1	Oral	10 MG, QD	2480	MG	Y				22334	10	MG	TABLET	QD
107771173	10777117	2	C	EXEMESTANE.	EXEMESTANE	1	Oral	25 MG, QD	6175	MG	Y				0	25	MG		QD

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
107771173	10777117	1	Breast cancer metastatic
107771173	10777117	2	Breast cancer metastatic

Outcome of event

Event ID	CASEID	OUTC COD
107771173	10777117	HO

Reactions reported

Event ID	CASEID	PT
107771173	10777117	Asthenia
107771173	10777117	Back pain
107771173	10777117	Cystitis noninfective
107771173	10777117	General physical health deterioration
107771173	10777117	Nausea
107771173	10777117	Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT	DUR	DUR COD
107771173	10777117	1	20131126	20140815	0
107771173	10777117	2	20131127	20140815	0